Company Filing History:

13 out of 656

Chiron Corporation

Cetus Oncology Corporation

patents

Years Active: 1994-2003

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6599706 - Recombinant PR-3 and assays employing the same (2003-07-29),

2. 6586222 - Recombinant PR-3 and compositions thereof (2003-07-01),

3. 6071512 - Infective protein delivery system (2000-06-06),

4. 6033667 - Method for detecting the presence of P-selectin (2000-03-07),

5. 5998378 - Compositions for the inhibition of TNF hormone formation and uses thereof (1999-12-07),

6. 5889156 - TNF deletion muteins (1999-03-30),

7. 5888814 - Recombinant host cells encoding TNF proteins (1999-03-30),

8. 5874077 - Human til cells expressing recombinant TNF prohormone (1999-02-23),

9. 5863797 - Gene fusion encoding a hypersecretor protein (1999-01-26),

10. 5856159 - Production of galactosyltransferase (1999-01-05),

11. 5849586 - Infective protein delivery system (1998-12-15),

12. 5843693 - Assay method for screening for inhibitors of proTNF conversion (1998-12-01),

13. 5800815 - Antibodies to P-selectin and their uses (1998-09-01),

14. 5702705 - Antibody methods for the treatment of a hormone-mediated disease (1997-12-30),

15. 5686259 - Assay method for the detection of 26kd TNF prohormone (1997-11-11),

Title: A Closer Look at Inventor Carl F Perez

Introduction:

Carl F Perez, a prolific inventor based in Berkeley, CA (US), is known for his remarkable contributions to the field of biotechnology. With an impressive portfolio of 17 patents, Perez has made significant strides in the development of novel methods and materials for various applications.

Latest Patents:

Among his latest patents is "Recombinant PR-3 and assays employing the same," which focuses on the production of purified, active recombinant human neutrophil protease, PR-3. This invention has far-reaching implications, including the discovery of inhibitors for the excessive release of mature, active TNF&agr;, as well as methods for identifying inhibitors of TNF&agr; conversion to its mature active form. Another notable patent is "Recombinant PR-3 and compositions thereof," which further advances the production and applications of PR-3 in the biotechnological realm.

Career Highlights:

Perez has garnered invaluable experience through his tenure at esteemed companies such as Chiron Corporation and Cytel Corporation. His innovative spirit and dedication to scientific advancement have been instrumental in shaping the biotech landscape.

Collaborations:

Throughout his career, Perez has collaborated with industry pioneers and visionaries, including notable coworkers such as Michael Kriegler and Robert F Halenbeck. These collaborations have not only enriched his work but have also fostered a culture of innovation and excellence.

Conclusion:

Inventor Carl F Perez's relentless pursuit of excellence and his groundbreaking inventions in the field of biotechnology underscore his status as a trailblazer in the industry. His innovative mindset, coupled with a passion for pushing boundaries, continues to drive meaningful advancements in the realm of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.